Nephrology and Hypertension, Children's Hospital of Michigan, Wayne State University School of Medicine, Detroit, MI, USA.
Division of Pediatric Urology, Oregon Health & Science University, Portland, OR, USA.
J Pediatr Urol. 2017 Dec;13(6):616.e1-616.e6. doi: 10.1016/j.jpurol.2017.03.040. Epub 2017 Jun 1.
Technetium-99m dimercaptosuccinic acid (DMSA) renal scans are used in the diagnosis of renal scarring. In the Randomized Intervention for Children with Vesicoureteral Reflux (RIVUR) trial that randomized 607 children, DMSA renal scans were used for evaluating the presence and the severity of renal scarring.
The aim was to determine interobserver variability in reporting of DMSA renal scans in the RIVUR trial.
We compared DMSA renal scan reports for renal scarring and acute pyelonephritis from all non-reference local radiologists (ALRs) at study sites with adjudicated as well as non-adjudicated reports from two reference radiologists (RRs) of the RIVUR trial. Two-way comparisons of concordant and discrepant responses were analyzed using an unweighted kappa statistic between the ALR and the adjudicated RR interpretations. All analyses were performed using SAS v 9.4 (SAS institute 2015) and significance was determined at the 0.05 level.
Of the 2872 kidneys evaluated, adjudicated RR reports had 119 (4%) kidneys with renal scarring compared with 212 (7%) by the ALRs. For 79% kidneys the grading for scarring reported by ALRs was either upgraded (24%) or downgraded (55%) by RRs. For acute pyelonephritis (n = 2924), adjudicated RR reports had 85 (3%) kidneys with pyelonephritis compared with 151 (5%) by the ALRs. For 85% kidneys, the grading for pyelonephritis reported by the ALRs was either upgraded (28%) or downgraded (57%) by the RRs. A three-way comparison revealed that all three (RR1, RR2, and ALR) agreed over presence of renal scarring in 19% cases and two of the three agreed in 80% cases. The respective numbers for pyelonephritis were 13% and 84%. The agreement rate for all DMSA scan reports between the RRs and the ALRs was 93%.
The study revealed significant interobserver variability in the reporting of abnormal DMSA renal scans compared with the previously published studies. A noteworthy limitation was a lack of uniformity in local reporting of the scans.
Our study highlights the need for optimizing the clinical yield of DMSA renal scans by more specific guidelines, particularly for standardized and uniform interpretation.
锝-99m 二巯丁二酸(DMSA)肾扫描用于诊断肾瘢痕。在随机干预儿童反流性膀胱输尿管(RIVUR)试验中,对 607 名儿童进行了随机分组,DMSA 肾扫描用于评估肾瘢痕的存在和严重程度。
旨在确定 RIVUR 试验中报告 DMSA 肾扫描的观察者间变异性。
我们比较了研究现场所有非参考放射科医生(ALR)的 DMSA 肾扫描报告与 RIVUR 试验中两位参考放射科医生(RR)的裁决和非裁决报告之间的肾瘢痕和急性肾盂肾炎。使用未加权 Kappa 统计量比较 ALR 和裁决 RR 解释之间的一致和不一致反应的双向比较。所有分析均使用 SAS v 9.4(SAS Institute 2015)进行,在 0.05 水平上确定显著性。
在评估的 2872 个肾脏中,裁决 RR 报告有 119 个(4%)肾脏有肾瘢痕,而 ALR 报告有 212 个(7%)。对于 79%的肾脏,ALR 报告的瘢痕分级要么升级(24%),要么降级(55%)。对于急性肾盂肾炎(n=2924),裁决 RR 报告有 85 个(3%)肾脏有肾盂肾炎,而 ALR 报告有 151 个(5%)。对于 85%的肾脏,ALR 报告的肾盂肾炎分级要么升级(28%),要么降级(57%)。三次比较表明,RR1、RR2 和 ALR 均在 19%的病例中一致存在肾瘢痕,而在 80%的病例中三者中有两者一致。相应的肾盂肾炎数字分别为 13%和 84%。RR 和 ALR 之间所有 DMSA 扫描报告的一致性率为 93%。
该研究显示,与之前发表的研究相比,在报告异常 DMSA 肾扫描方面存在显著的观察者间变异性。一个值得注意的局限性是缺乏对扫描的局部报告的一致性。
我们的研究强调需要通过更具体的指南来优化 DMSA 肾扫描的临床效果,特别是对于标准化和统一的解释。